Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 14/20 | 0.53 |
| ▸ | PIK3CA | P42336 | 4/20 | 0.53 |
| ▸ | PIK3CB | P42338 | 2/20 | 0.53 |
| ▸ | PIK3CG | P48736 | 2/20 | 0.53 |
| ▸ | EGFR | P00533 | 1/20 | 0.49 |
| ▸ | GPR119 | Q8TDV5 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30140106 | 0.89 | PIK3CD (0.54) | PIK3CDPIK3CAPIK3CBPIK3CGEGFR | |
| SCHEMBL17687796 | 0.84 | PIK3CD (0.57) | PIK3CDPIK3CAPIK3CBPIK3CGGPR119 | |
| SCHEMBL17687793 | 0.84 | PIK3CD (0.57) | PIK3CDPIK3CAPIK3CBPIK3CGGPR119 | |
| SCHEMBL29834734 | 0.83 | PIK3CD (0.62) | PIK3CDPIK3CAPIK3CBPIK3CGEGFR | |
| SCHEMBL29834791 | 0.83 | PIK3CD (0.62) | PIK3CDPIK3CAPIK3CBPIK3CGEGFR | |
| SCHEMBL26111113 | 0.83 | GPR119 (0.49) | PIK3CDEGFRGPR119 | |
| SCHEMBL30639958 | 0.83 | GPR119 (0.49) | PIK3CDEGFRGPR119 | |
| SCHEMBL23537917 | 0.81 | PIK3CD (0.52) | PIK3CDPIK3CAPIK3CBPIK3CG | |
| SCHEMBL30140074 | 0.81 | PIK3CD (0.54) | PIK3CDPIK3CAPIK3CBPIK3CG | |
| SCHEMBL23537918 | 0.81 | PIK3CD (0.52) | PIK3CDPIK3CAPIK3CBPIK3CG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022266426-A1 | 6-(HETEROCYCLOALKYL-OXY)-QUINAZOLINE DERIVATIVES AND USES THEREOF | BLACK DIAMOND THERAPEUTICS, INC. (US) | 2022-12-22 | — | — | WO | disclosed |